GGrantIndex
← Leaderboards

Katherine L. Wisner

Case Western Reserve University

Google Scholar ↗PubMed ↗ORCID ↗
$16,545,298
Attributed
$17,636,005
Total exposure
11
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY2005–23
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$21,536,094 · 12

By mechanism

R01$15,858,443 · 6
U54$4,887,096 · 2
R21$440,000 · 1
P41$294,555 · 1
R13$56,000 · 2

Top collaborators

Others in their field

Top investigators on “Pregnancy”

Research focus

PregnancyWomanMothersPostpartum PeriodBaseAntidepressive AgentsResponsePharmacotherapyPregnant WomenPharmaceutical PreparationsDepressive SymptomsClinical ResearchMental DepressionHuman SubjectClinical TrialsInfantDoseDesignResearch PersonnelProgramsDrug KineticsSafetyMajor Depressive DisorderCaring

Grant awards (44)

ENDEAVOR TO STOP NAUSEA/VOMITING ASSOCIATED WITH PREGNANCY (E-SNAP)$200,000
R21 · FY2023 · HD · contact PI
ENDEAVOR TO STOP NAUSEA/VOMITING ASSOCIATED WITH PREGNANCY (E-SNAP)$240,000
R21 · FY2022 · HD · contact PI
Pharmacogenetic Risks Operating in Failure Of Nifedipine to Delay Pre-Term Birth (PROFOUND-PTB)$331,426
R01 · FY2020 · HD
Optimizing Pharmacotherapy for Depression during Pregnancy (OPTI-MOM)$759,355
U54 · FY2019 · HD · contact PI
Molecular basis of altered drug metabolism during pregnancy$561,936
R01 · FY2019 · HD
OPTI-MOM Administrative Core$152,502
U54 · FY2019 · HD · contact PI
Optimizing Pharmacotherapy for Depression during Pregnancy (OPTI-MOM)$769,521
U54 · FY2018 · HD · contact PI
Molecular basis of altered drug metabolism during pregnancy$638,285
R01 · FY2018 · HD
OPTI-MOM Administrative Core$152,503
U54 · FY2018 · HD · contact PI
Optimizing Pharmacotherapy for Depression during Pregnancy (OPTI-MOM)$777,549
U54 · FY2017 · HD · contact PI
Molecular basis of altered drug metabolism during pregnancy$649,768
R01 · FY2017 · HD
OPTI-MOM Administrative Core$152,503
U54 · FY2017 · HD · contact PI
Optimizing Pharmacotherapy for Depression during Pregnancy (OPTI-MOM)$779,309
U54 · FY2016 · HD · contact PI
OPTI-MOM Administrative Core$251,955
U54 · FY2016 · HD · contact PI
Optimizing Pharmacotherapy for Depression during Pregnancy (OPTI-MOM)$814,355
U54 · FY2015 · HD · contact PI
OPTI-MOM Administrative Core$277,544
U54 · FY2015 · HD · contact PI
Optimizing Treatment of Mental Illness during Pregnancy:Improving Infant Outcomes$6,000
R13 · FY2013 · HD · contact PI
Transdermal Estradiol for Postpartum Depression.$664,615
R01 · FY2010 · MH · contact PI
Identification and Therapy of Postpartum Depression$619,734
R01 · FY2010 · MH · contact PI
Antimanic Use During Pregnancy$595,822
R01 · FY2010 · MH · contact PI
Marce Society (International Society for the Understanding, Prevention, and treat$50,000
R13 · FY2010 · MH · contact PI
Transdermal Estradiol for Postpartum Depression.$663,934
R01 · FY2009 · MH · contact PI
Antimanic Use During Pregnancy$635,032
R01 · FY2009 · MH · contact PI
Identification and Therapy of Postpartum Depression$627,258
R01 · FY2009 · MH · contact PI
Transdermal Estradiol for Postpartum Depression.$657,227
R01 · FY2008 · MH · contact PI
Antimanic Use During Pregnancy$632,046
R01 · FY2008 · MH · contact PI
Identification and Therapy of Postpartum Depression$617,787
R01 · FY2008 · MH · contact PI
Transdermal Estradiol for Postpartum Depression.$666,156
R01 · FY2007 · MH · contact PI
Antimanic Use During Pregnancy$653,969
R01 · FY2007 · MH · contact PI
Identification and Therapy of Postpartum Depression$622,456
R01 · FY2007 · MH · contact PI
Antimanic Use During Pregnancy$667,898
R01 · FY2006 · MH · contact PI
Identification and Therapy of Postpartum Depression$643,684
R01 · FY2006 · MH · contact PI
Prevention of Recurrent Postpartum Major Depression$480,898
R01 · FY2005 · MH
ANTIDEPRESSANT USE DURING PREGNANCY$787,526
R01 · FY2004 · MH
Prevention of Recurrent Postpartum Major Depression$462,745
R01 · FY2004 · MH
ANTIDEPRESSANT USE DURING PREGNANCY$625,433
R01 · FY2003 · MH
SSRI Rx: Effects on Self Efficacy and Maternal Role$223,997
R01 · FY2003 · MH
ANTIDEPRESSANT USE DURING PREGNANCY$630,980
R01 · FY2002 · MH
FAMILY HISTORY IN WOMEN W/ POST PARTUM DEPRESS: FAMILIAL &BEHAVIORAL DISORDERS$294,555
P41 · FY2001 · RR
POSTPARTUM DEPRESSION--NORTRIPTYLINE VS SERTRALINE$252,882
R01 · FY2001 · MH
POSTPARTUM DEPRESSION--NORTRIPTYLINE VS SERTRALINE$80,783
R01 · FY2001 · MH
ANTIDEPRESSANT USE DURING PREGNANCY$626,825
R01 · FY2000 · MH
POSTPARTUM DEPRESSION--NORTRIPTYLINE VS SERTRALINE$537,341
R01 · FY2000 · MH
FAMILY HISTORY IN WOMEN W/ POST PARTUM DEPRESS: FAMILIAL &BEHAVIORAL DISORDERS$0
P41 · FY2000 · RR